Thermo Fisher Scientific

  1. Accelerating Science
  2. Life in the Lab
    3. /
  3. Industry Insights
    4. / Practical Considerations for Choosing a Cell-Based Assay for Microplate Readers

Practical Considerations for Choosing a Cell-Based Assay for Microplate Readers

Written by | Published: 04.13.2026

Authors: Penny J. Jensen & Janaki Narahari

Choosing the right cell-based assay is a critical step in designing reliable experiments, but with so many options available, it can be difficult to know where to start. If you’re wondering how to choose a cell-based assay, the answer depends on your biological question, the type of cells you’re working with, and how you plan to measure results. Cell health assays—including viability, cytotoxicity, and proliferation assays—are widely used across cell biology, drug discovery, and biotechnology to evaluate cell growth, function, and response to treatments. In this guide, we’ll walk through the different types of cell-based assays, the detection technologies behind them, and how to choose the right approach for your workflow, including key considerations for microplate reader-based applications.

How Cell-based Assays Measure Cell Health and Why Detection Matters

When learning how to choose a cell-based assay, it’s important to understand what different assays actually measure and how those measurements are generated. Cell-based assays are designed to evaluate various aspects of cell health, including viability, cytotoxicity, proliferation, and specific biological responses to treatment and are widely used in cell biology, biomedical research, drug development, and biotechnology.

For example, cell viability assays (CVA) examine the number of metabolically active cells, while cytotoxicity assays measure loss of membrane integrity as an indicator of cell damage or death. Other assays, such as proliferation or apoptosis assays, enable more specific insights into cell behavior and mechanisms of action. Together, these approaches give a more complete picture of how cells respond under different experimental conditions across diverse range of research applications, from routine cell culture monitoring to advanced therapeutic development.

Just as important as what is being measured is how the signal is detected. Detection technologies—such as absorbance, fluorescence, and luminescence—translate biological activity into measurable outputs. Each detection method has distinct advantages and limitations that can affect sensitivity, dynamic range, and susceptibility to interference. Understanding these differences is a key step in choosing the right cell functional assay and help ensure reliable, interpretable results.

What are the Different Types of Cell Health Assays

In practice, measurement of cell viability is based on either monitoring cell growth or cell death. Cytotoxicity assays that measure cell death report loss of membrane integrity and cell damage/lysis (dead/dying cells) while viability assays typically generate a biochemical signal that correlates with the number of metabolically active cells.

Membrane integrity assays (Cytotoxicity)

These assays distinguish live from membrane-compromised cells using membrane-impermeant dyes or leakage-based readouts.

Dye exclusion / uptake: Healthy cells exclude membrane-impermeant dyes, while compromised cells take them up and are quantified based on optical signal. The most common approach is trypan blue, a colorimetric dye used with light microscopy for cell counting. There are also fluorescent membrane-impermeant dyes that enter cells with compromised membranes and bind intracellular DNA or protein that enable higher-throughput workflows. Such dyes include To-PRO-3 iodide, 7-AAD, LIVE/DEAD and SYTOX dyes in multiple spectral variants. [1]

Leakage-based cytotoxicity: Leaked enzyme assays quantify enzyme activity in the supernatant after membrane damage including CyQuant LDH and G6PD Assays (Figure 1). These enable a robust cytotoxicity readout that pairs well with many viability assays for multiplexing and help distinguish between reduced metabolic activity and actual cell death (Figure 2).

Figure 1. CyQUANT LDH cytotoxicity assay mechanism and workflow. LDH is released from dead or dying cells and, through a series of reactions, generates a red formazan product that can be measured using a microplate reader.

Figure 2. Multiplexing to simultaneously detect changes in cytotoxicity and viability. A549 cells were treated with gambogic acid after overnight incubation. Post-treatment, medium was collected for LDH-based cytotoxicity measurement (CyQUANT LDH Cytotoxicity Assay), while cell viability was assessed in the same wells using alamarBlue HS or PrestoBlue HS. An increase in LDH concentration representing an increase in cytotoxicity is displayed (left y-axis).

Metabolic activity assays (viability/functional state)

Metabolic assays estimate the number of viable cells by measuring biochemical activity such as cellular reducing potential, enzyme activity, or ATP abundance. Because metabolic dysfunction can occur before complete membrane rupture, these assays can detect sublethal stress that dye exclusion may miss. [1] These assays are commonly used in applications such as drug screening and cell proliferation studies where early changes in cell health are important.

Common metabolic assay formats compatible with microplate readers include:

Functional Response Assays (proliferation and apoptosis)

These assays mostly utilize fluorescent dyes and are often grouped with “cell health” assays, but they measure different endpoints than viability alone: Proliferation assays measure actively dividing cells, whereas mechanism-of-death assays identify cells that are dead or dying due to apoptosis or necrosis.

  • Proliferation / DNA synthesis: EdU/BrdU assay report DNA replication (S-phase entry) and are best suited answering the question, “Are cells actively dividing?” rather than simply “Are they alive?” DNA synthesis is quantified by incorporating EdU or BrdU into new DNA and detecting it using click chemistry or immunostaining (Figure 3).
  • Apoptosis / mechanism: Annexin V and caspase-3/7 assays indicate apoptosis pathways. Annexin V is commonly paired with a membrane-impermeant dye (PI) to distinguish viable, early apoptotic, and late apoptotic/necrotic populations.

Figure 3. Click-iT EdU proliferation assay for microplates. Following incorporation of EdU (a thymidine analog) into newly synthesized DNA, horseradish peroxidase (HRP) is covalently linked via a highly specific click reaction. Addition of the Amplex™ UltraRed reagent generates a fluorescent signal, enabling sensitive and reliable measurement of mammalian cell proliferation in a microplate format.

Explore the Selection Guide for Cell Health Assays

How Detection Technologies Impact Assay Performance

Different detection technologies convert biological signals into measurable data in distinct ways. Understanding how these technologies work is important for selecting the right combination of assay and instrument. Detection method directly impacts sensitivity, dynamic range, susceptibility to interference, and overall data quality, making it a critical factor in aligning your assay choice with your experimental goals.

Absorbance (photometric) Detection

Photometric detection measures changes in light absorbance caused by colored reaction products. Many traditional cell viability assays rely on this approach, such as tetrazolium-based assays where metabolically active cells reduce substrates into colored formazan products.

Absorbance-based assays are often preferred for simple, cost-effective workflows where large differences in cell number are expected. However, these assays may have lower sensitivity, a narrower dynamic range, and are susceptible to optical interference from colored compounds, media components, turbidity or precipitate, and debris.[2]   

Fluorescence Detection

Fluorescence assays measure light emitted from fluorescent molecules following excitation and are commonly used in cell-based assays such as Calcein AM or LIVE/DEAD formats. When choosing a cell assay, fluorescence detection is often preferred for its higher sensitivity compared to absorbance methods and its ability to support multiplexing, enabling multiple biological readouts to be measured within the same well.

However, fluorescence-based assays can be more susceptible to interference, particularly in screening applications. Compound autofluorescence, quenching effects, and the inner filter effect can all impact signal accuracy and lead to false positives or negatives if not properly controlled. Careful assay design, including appropriate controls and spectral planning, is essential to ensure reliable results.[3]

Luminescence Detection

Luminescence measures light produced by a chemical reaction and does not require external excitation, which helps reduce background from optical artifacts. Most luminescent viability kits report amount of ATP using luciferase/luciferin chemistry, such as the GlowQuant ATP Cell Viability Assay (Figure 4). Cells are commonly lysed to release ATP, then light output is measured on a luminescence-compatible microplate reader. [1]

Figure 4. Schematic workflow of the GlowQuant ATP Cell Viability assay. Arapid, easy-to-use kit with a one-step add-and-read format. Add the reagent to the cells, mix to incorporate and incubate for 10-20 minutes. Measure the luminescence using a luminometer or microplate reader (e.g. Varioskan ALF Multimode Microplate Reader), where signal intensity is proportional to the cellular ATP levels. Damaged or non-viable cells will innately have lower ATP activity and generate less signal.

Luminescent assays are popular in high-throughput contexts because they tend to be sensitive, have a broad linear dynamic range, and are available in flash or glow formats. This makes these assays highly amenable to high-throughput screening mechanisms, as cells can be seeded at low densities with low volumes while still obtaining measurable signal. Signal duration depends on both the reagent formulation and the luciferase properties (glow formats often use engineered luciferases plus stabilizing buffers to extend signal half-life).[4,5]

Flash Assays

Such assays emit a very intense signal that decays rapidly. For such assays, readers that support reagent injection/dispensing (e.g. the Varioskan LUX multimode microplate reader) can improve timing consistency by enabling dispense-and-read workflows. In many ATP assays the flash reaction is not very convenient; therefore, most applications utilize the more stable, long-term light emission with glow kinetics. [5]

Glow Assays

Assays using glow-type kinetics are more commonly used in high-throughput settings where the number of samples is large, necessitating longer signal duration.

Key Factors to Consider when Choosing a Cell Viability Assay

When determining how to choose a cell health assay, it’s important to balance biological relevance, detection performance, and practical workflow considerations.

Sensitivity and Dynamic Range

Assays with higher sensitivity enable detection of subtle changes in cell health, particularly in low-density cultures or when treatment effects are minimal, whereas broader dynamic range allows measurements across a wide span of cell densities and signal intensities without compromising linearity or accuracy.

Cell Type and Assay Format

Different cell types vary widely in metabolic activity, size, and growth behavior. An assay optimized for rapidly dividing cell lines may not perform well with primary cells, stem cells, or slow-growing models. Compatibility with 2D versus 3D cultures and suspension versus adherent cells should also be considered when selecting an assay.

Throughput and Workflow Compatibility

High-throughput applications place different demands on assays than low-throughput, mechanistic studies. Factors such as incubation time, reagent stability, and the number of handling steps can significantly impact reproducibility and scalability, particularly in automated workflows.

Microplate Reader Capabilities

Not all microplate readers are optimized for every detection mode. Detector sensitivity, wavelength flexibility, filter quality, injector availability, and software features can influence assay performance and data quality. Aligning assay chemistry and reader specifications is important to obtaining reliable results.

Thermo Scientific Microplate Reader Options

Thermo Scientific offers a range of microplate readers tailored to different assay needs and levels of flexibility. For routine absorbance applications, the Multiskan Ease Absorbance Microplate Photometer  provides straightforward, reliable measurements, while the Multiskan SkyHigh Microplate Spectrophotometer enables full-spectrum UV/Vis scanning for more advanced quantification and method development. For laboratories requiring broader application support, the Varioskan ALF and Varioskan LUX Multimode Microplate Readers allow versatile performance across absorbance, fluorescence, and luminescence assays, supporting everything from basic measurements to more complex and sensitive workflows.

Learn More about Microplate Readers and Request a Demo

Key Considerations for Choosing a Cell Assay

1. Start with the Biological Question

When determining how to choose a cell assay, the most important step is defining the biological question you are trying to answer:

  • “How many metabolically active cells are there right now?” → metabolic assays (resazurin, ATP, enzyme activity).
  • “Is my treatment killing cells (membrane damage/lysis)?” → Use cytotoxicity assays such as LDH release; consider pairing with a viability assay for additional context.
  • “Is the effect cytostatic vs cytotoxic?” → Include a proliferation endpoint (EdU/BrdU) alongside viability measurements.
  • “What mechanism of cell death is occuring?” → Use apoptosis or mechanism assays (Annexin V ± PI, caspases); cytometry or imaging often provides clearer interpretation than plate-based formats.

2. Decide: Endpoint vs Kinetic, Lytic vs Non-Lytic

  • If repeated measurements on the same wells are required, avoid lytic ATP assays, which are best suited for endpoint measurements.
  • If only a single timepoint is needed, endpoint assays are typically simpler and more reproducible.

3. Match Detection to your Interference Risk

  • Testing colored or absorbing compounds, nanoparticles, turbid samples, or precipitating materials? Be cautious with absorbance-based assays and validate results with an orthogonal detection method
  • Screening small molecules? Expect autofluorescence and inner filter effects—plan counter-screens or consider luminescence-based assays when possible

4. Consider Cell Model and Assay Compatibility

  • Cell type and growth format (adherent vs suspension) can significantly impact assay performance
  • Monolayer cultures are generally well-suited for imaging-based assays, while lytic assays offer greater flexibility across formats
  • 3D cultures, spheroids, and organoids may present diffusion and penetration challenges; longer incubation times or stronger lysis chemistries may be required

5. Plan Multiplexing (often underutilized)

Combining multiple readouts can provide a more complete understanding of cell response. A common approach is:

  • Viability (metabolic or ATP) + Cytotoxicity (LDH)[6]

This combination helps distinguish between reduced metabolic activity and actual cell death, which can otherwise appear similar depending on the timepoint.

Assay TypeReagentsPrimary MeasurementTypical Use CasesPotential Confounders
Metabolic ViabilityResazurin (AlamarBlue, PrestoBlue, Vybrant), MTT/XTT/MTS/WST-1, enzyme activity assaysMetabolic activity (redox/enzymatic capacity) as a measure for viable functionFast viability snapshots; many routine toxicity screensMetabolism can drop without death (stress, mitochondrial inhibitors). MTT-family is often absorbance-based, so colored/turbid/precipitating samples can distort signal.
ATP ViabilityATP luminescence assays (GlowQuant)ATP abundance as a measure for viable cellsHigh sensitivity; great endpointsUsually lytic → not ideal for repeated reads on the same wells. ATP can fall early in stress.
Cell Number/Biomass ProxyCyQUANT (DNA content), DNA stainsTotal DNA ≈ cell number (more “how many cells”)When metabolism is a confounder; tracking growth/proliferation trendsDNA can persist after death for a while; confounding the results, as well as cell cycle changes can shift DNA content interpretation.
Membrane Damage (cytotoxicity)LDH releaseLoss of membrane integrity / lysisDistinguishing “dead/dying” from “just slowed”Captures damage/lysis, not growth arrest. Timing matters, early apoptosis may show low LDH.
ProliferationEdU/BrdU incorporationDNA synthesis / divisionSeparating cytostasis vs cytotoxicityA treatment can block division without killing; pair with viability and/or LDH.
Death MechanismAnnexin V ± PI, caspasesApoptosis markers / pathway activityMechanistic follow-upBest with cytometry/imaging;plate-average readouts can hide mixed subpopulations.

Key Takeaways

  • Choosing the right cell assay depends on your biological question, detection method, and experimental workflow
  • Different assay types, including metabolic, cytotoxicity, and functional assays provide complementary insights into cell health and behavior
  • Detection technologies such as absorbance, fluorescence, and luminescence directly impact sensitivity, dynamic range, and data quality
  • Assay selection should account for cell type, throughput needs, and microplate reader capabilities
  • Combining multiple assay types (e.g., viability and cytotoxicity) can improve interpretation and reduce misleading results

FAQs

Are luminescence assays always better than absorbance assays?

Not necessarily. While luminescence assays often offer higher sensitivity, absorbance assays may be sufficient for robust, high-cell-number applications and can be more cost-effective for routine use.

How do I choose the right cell assay?

The right cell assay depends on your experimental goal. If you need to measure viable cells, metabolic assays such as ATP or resazurin are commonly used. If your goal is to detect cell death, cytotoxicity assays such as LDH are more appropriate. For understanding cell behavior, such as proliferation or apoptosis, functional assays like EdU or Annexin V are recommended. Detection method, cell type, and workflow requirements should also be considered.

Can cell assays be multiplexed with other readouts?

Yes, many fluorescence- and luminescence-based assays are designed for multiplexing. Combining multiple readouts—such as viability and cytotoxicity—can provide a more complete understanding of cell response and help distinguish between reduced metabolic activity and actual cell death.

How can compounds interfere with cell assay results?

Test compounds may absorb light, fluoresce, or affect cellular metabolism independently of cell viability. These effects can lead to inaccurate results if not accounted for. Using appropriate controls, selecting the right detection method, and validating findings with orthogonal assays can help minimize interference.

References

  1. Vishven Naveen, K., Tyagi, A., Ibrahium, O. M. H., Fischer, R. E. A. W., & Ostafe, R. (2026). From dye exclusion to high-throughput screening: A review of cell viability assays and their applications. Biotechnology Advances, 87, 108764. https://doi.org/10.1016/j.biotechadv.2025.108764
  • Ghasemi, M., Turnbull, T., Sebastian, S., & Kempson, I. (2021). The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. International Journal of Molecular Sciences, 22(23), 12827. https://doi.org/10.3390/ijms222312827
  •  Friganović, T., & Weitner, T. (2023). Reducing the Inner Filter Effect in Microplates by Increasing Absorbance? Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c01295

For Research Use Only. Not for use in diagnostic procedures.